Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Change in Taxes (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Change in Taxes for 17 consecutive years, with -$324.0 million as the latest value for Q4 2025.

  • Quarterly Change in Taxes fell 367.77% to -$324.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$4.0 million through Dec 2025, up 99.68% year-over-year, with the annual reading at -$4.0 million for FY2025, 99.68% up from the prior year.
  • Change in Taxes for Q4 2025 was -$324.0 million at Bristol Myers Squibb, down from $887.0 million in the prior quarter.
  • The five-year high for Change in Taxes was $1.0 billion in Q4 2023, with the low at -$2.1 billion in Q2 2023.
  • Average Change in Taxes over 5 years is -$217.6 million, with a median of -$134.0 million recorded in 2021.
  • The sharpest move saw Change in Taxes tumbled 2222.73% in 2021, then soared 354.89% in 2025.
  • Over 5 years, Change in Taxes stood at -$222.0 million in 2021, then tumbled by 401.35% to -$1.1 billion in 2022, then surged by 193.8% to $1.0 billion in 2023, then plummeted by 88.41% to $121.0 million in 2024, then plummeted by 367.77% to -$324.0 million in 2025.
  • According to Business Quant data, Change in Taxes over the past three periods came in at -$324.0 million, $887.0 million, and -$621.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.